2 hours Chase Investment Counsel Corp Purchases Shares of 91,337 Halozyme Therapeutics, Inc. (NASDAQ:HALO) MarketBeat
Chase Investment Counsel Corp purchased a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 91,337 shar…